A clinical study of the V540A vaccine in healthy adults (V540A-001)
V540A-001
Phase 1 other active
Quick answer
A clinical study of the V540A vaccine in healthy adults (V540A-001) for Human Papilloma virus is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Human Papilloma virus
- Phase
- Phase 1
- Modality
- other
- Status
- active